Dabbous Monique, François Clément, Chachoua Lylia, Toumi Mondher
Public Health Department - Research Unit EA, Aix-Marseille Université, Marseille, France.
Creativ-Ceutical, Paris, France.
J Mark Access Health Policy. 2019 Mar 4;7(1):1579597. doi: 10.1080/20016689.2019.1579597. eCollection 2019.
: Drug prices in the United States are the highest in the world, restricting access to the domestic lower income population. President Trump campaigned heavily on promises to reduce drug prices.: A literature review was conducted through PUBMED, EMBASE, Media and grey literature to consolidate and analyze publications addressing President Trump's promises from the campaign trail as well as the shortcomings and achievements of the Trump administration.: Major promises ranged from repealing and replacing Obamacare, expanding coverage, allowing cross-state insurance purchasing, and reducing drug prices. Main accomplishments of the Trump administration have been two executive orders (13765 and 13813), the proposition of the American Health Care Act, and the passing of the Tax Cuts and Jobs Act of 2017. The American Patients First blueprint further revealed the administration's strategies for lowering drug prices. The administration has also engaged in unconventional strategies, such as via bilateral leverage directly with trade partners.: The Trump administration has not yet been able to fulfill the major campaign promises, primarily the ones requiring legislative and/or administrative action. If enough legislative action is accomplished to implement the Trump administration's promises, the effects on the pharmaceutical industry could be direct, yet minimal, unless Medicare can directly negotiate with manufacturers.
美国的药品价格是全球最高的,这限制了国内低收入人群获取药品。特朗普总统在竞选时大力承诺降低药品价格。
通过PubMed、EMBASE、媒体和灰色文献进行了文献综述,以整合和分析有关特朗普总统竞选承诺以及特朗普政府的缺点和成就的出版物。
主要承诺包括废除和取代奥巴马医改、扩大医保覆盖范围、允许跨州购买保险以及降低药品价格。特朗普政府的主要成就包括两项行政命令(第13765号和第13813号)、《美国医疗保健法案》的提议以及2017年《减税与就业法案》的通过。《美国患者优先》蓝图进一步揭示了政府降低药品价格的策略。政府还采取了非常规策略,例如直接与贸易伙伴进行双边施压。
特朗普政府尚未能够兑现主要竞选承诺,主要是那些需要立法和/或行政行动的承诺。如果完成足够的立法行动来兑现特朗普政府的承诺,对制药行业的影响可能是直接的,但很小,除非医疗保险能够直接与制造商谈判。